Sparian Biosciences, Inc.
Clinical trials sponsored by Sparian Biosciences, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pain pill SBS-147 enters first human safety trial Results expected Jan 2027 (estimated)